ZELTIQ Aesthetics, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference

PLEASANTON, CA -- (Marketwired) -- 08/05/16 -- ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Taylor Harris, Senior Vice President and Chief Financial Officer, is scheduled to present at the Canaccord Genuity 36th Annual Growth Conference in Boston, MA.

                                                                            
          Event:          Canaccord Genuity 36th Annual Growth Conference   
          Date:           Thursday, August 11, 2016                         
          Time:           11:00 am ET / 8:00 am PT                          
          Participant:    Taylor Harris, Senior Vice President and Chief    
                          Financial Officer                                 
                                                                            

Audio webcast of the Company's presentation will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.

About ZELTIQ® Aesthetics
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting system, is designed to selectively reduce unwanted fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.

Source: ZELTIQ Aesthetics, Inc.

You May Also Be Interested In

• Form 8.3 - [ANIMALCARE GROUP PLC - 19 06 2026] - (CGWL)
• Northern Trust Appointed to Support TirNua Capital Partners’ Inaugural Infrastructure Fund
• Danske Bank share buy-back programme: transactions in week 25